We are live on ! Find out more
ACRS icon

Aclaris Therapeutics
ACRS

62 hedge funds and large institutions have $46.1M invested in Aclaris Therapeutics in 2020 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 21 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more capital invested

Capital invested by funds: $33.4M → $46.1M (+$12.7M)

9.31% less ownership

Funds ownership: 77.28% → 67.97% (-9.3%)

13% less funds holding

Funds holding: 71 → 62 (-9)

38% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 21

43% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 21

Holders
62
Holders Change
-9
Holders Change %
-12.68%
% of All Funds
1.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
13
Reduced
21
Closed
21
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$5K

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$670K
2
Millennium Management
Millennium Management
New York
+$516K
3
BCM
Bridgeway Capital Management
Texas
+$368K
4
Jane Street
Jane Street
New York
+$271K
5
SSA
Schonfeld Strategic Advisors
New York
+$233K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$2.12M
2
ECM
Endurant Capital Management
California
-$1.19M
3
MP
MFN Partners
Massachusetts
-$886K
4
State Street
State Street
Massachusetts
-$789K
5
EC
EcoR1 Capital
California
-$745K
Name Holding Trade Value Shares
Change 		Change in
Stake
CG
51
Cutler Group
California
$5K – – –
Federated Hermes
52
Federated Hermes
Pennsylvania
$4K +$3.01K +2,248 +806%
Group One Trading
53
Group One Trading
Illinois
$4K +$3.35K +2,500 New
Wells Fargo
54
Wells Fargo
California
$3K -$67.1K -50,114 -96%
OSAM
55
O'Shaughnessy Asset Management
Connecticut
$2K +$1.81K +1,352 New
UBS Group
56
UBS Group
Switzerland
$1K -$24.7K -18,450 -97%
Northwestern Mutual Wealth Management
57
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
PCM
58
Prelude Capital Management
New York
$1K +$502 +375 New
JP Morgan Chase
59
JP Morgan Chase
New York
– -$240K -179,044 -100%
N
60
Nuveen
North Carolina
– -$115K -110,000 Closed
PAM
61
Panagora Asset Management
Massachusetts
– -$59K -57,155 Closed
AllianceBernstein
62
AllianceBernstein
Tennessee
– -$57K -55,200 Closed
RhumbLine Advisers
63
RhumbLine Advisers
Massachusetts
– -$54K -51,626 Closed
Citadel Advisors
64
Citadel Advisors
Florida
– -$53K -51,250 Closed
California State Teachers Retirement System (CalSTRS)
65
California State Teachers Retirement System (CalSTRS)
California
– -$49K -47,336 Closed
New York State Common Retirement Fund
66
New York State Common Retirement Fund
New York
– -$31K -29,649 Closed
PPA
67
Parametric Portfolio Associates
Washington
– -$19K -18,418 Closed
AIG
68
American International Group
New York
– -$19K -18,241 Closed
VOYA Investment Management
69
VOYA Investment Management
Georgia
– -$17K -16,490 Closed
WS
70
Wedbush Securities
California
– -$15K -14,000 Closed
SG Americas Securities
71
SG Americas Securities
New York
– -$14K -13,280 Closed
Victory Capital Management
72
Victory Capital Management
Texas
– -$14K -12,662 Closed
William Blair & Company
73
William Blair & Company
Illinois
– -$11K -10,600 Closed
State Board of Administration of Florida Retirement System
74
State Board of Administration of Florida Retirement System
Florida
– -$11K -10,377 Closed
Citigroup
75
Citigroup
New York
– -$10K -9,838 Closed
1 2
3
4

ACRS Hedge Fund Activity: Q2 2020 in Review

62 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Aclaris Therapeutics (ACRS) for Q2 2020, worth a combined $46.1M — up 38% from $33.4M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of ACRS and 12 opened new positions — a net loss of 9 holders — while 21 trimmed existing stakes and 13 added.

The largest buyer was Adage Capital Partners, adding an estimated $670K. The largest seller was BlackRock, cutting an estimated $2.12M.

  • 62 institutional investors held Aclaris Therapeutics (ACRS) as of Q2 2020, down from 71 in Q1 2020.
  • Funds reported $46.1M of Aclaris Therapeutics stock for Q2 2020, up 38% quarter-over-quarter.
  • 12 funds opened new Aclaris Therapeutics positions in Q2 2020 and 21 closed out, a net change of -9 holders.
  • The largest Aclaris Therapeutics buyer in Q2 2020 was Adage Capital Partners, an estimated $670K added.
  • The largest Aclaris Therapeutics seller in Q2 2020 was BlackRock, an estimated $2.12M sold.

Based on aggregated 13F filings for Q2 2020.